Equifax (NYSE:EFX) Stock, Quote.Headers.trade-ideas

Equifax

Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.

Earnings

Earnings Beats

Large Cap

News

Guidance

Dividends

Markets

Analyst Ratings

Trading Ideas

A month has gone by since the last earnings report for Equifax (NYSE: EFX). Shares have added about 11.1% in that time frame, outperforming the S&amp;P 500.

Why Is Equifax Up 11.1% Since Last Earnings Report?

Fintech news covering the emerging Financial Technology services sector

Fintech

Broadridge Financial Solutions, Inc. (NYSE: BR) reported mixed fourth-quarter fiscal 2024 results, with earnings beating the Zacks Consensus Estimate but revenues missing the same.

Broadridge&#39;s Q4 Earnings Surpass Estimates, Rise Y/Y

APTV

Aptiv PLC (NYSE: APTV) reported mixed second-quarter 2024 results, with earnings beating the Zacks Consensus Estimate but revenues missing the same.

Aptiv&#39;s Q2 Earnings Beat Estimates, Increase Y/Y

Equifax Inc

Effect Network

Enerflex Ltd

Equifax Launched A New Merchant Data Network, An Equifax Cloud-based Data Network To Help Provide Greater Visibility Into The Financial Profiles Of US Small Businesses

Barclays analyst Manav Patnaik maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and raises the price target from $300 to $380.

Price Target

Barclays Maintains Overweight on Equifax, Raises Price Target to $380

Across the recent three months, 12 analysts have shared their insights on Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Equifax, revealing an average target of $297.92, a high estimate of $340.00, and a low estimate of $271.00. This upward trend is apparent, with the current average reflecting a 11.75% increase from the previous average price target of $266.60.
<img src="https://www.benzinga.com/files/images/story/2024/1726142483_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Equifax among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$271.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$307.00</td>
<td>$277.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$340.00</td>
<td>-</td>
</tr>
<tr>
<td>Arthur Truslove</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$304.00</td>
<td>$263.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$300.00</td>
<td>$273.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$305.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$272.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$277.00</td>
<td>$246.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$290.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$320.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Heather Balsky</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$286.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Scott Wurtzel</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$275.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Equifax. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Equifax's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Equifax's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Equifax analyst ratings.</a>
<h2>All You Need to Know About Equifax</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Unraveling the Financial Story of Equifax</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Equifax displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 8.57%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Equifax's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 11.46% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 3.54%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Equifax's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.34%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Equifax's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.17, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 12 Analysts Discuss Equifax Stock

Morgan Stanley analyst Toni Kaplan maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Equal-Weight and raises the price target from $250 to $271.

Morgan Stanley Maintains Equal-Weight on Equifax, Raises Price Target to $271

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 10 years by 3.84% on an annualized basis producing an average annual return of 14.31%. Currently, Equifax has a market capitalization of $36.14 billion. 
Buying $100 In EFX: If an investor had bought $100 of EFX stock 10 years ago, it would be worth $380.13 today based on a price of $292.08 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725895815_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today

Workday's Employment Verification Connector For Equifax Will Help Workday Customers Verify Employment and Income Details Faster and More Efficiently, Streamlining Operations and Reducing Costs
PLEASANTON, Calif. and ATLANTA, Aug. 22, 2024 /PRNewswire/ --&nbsp;<a href="https://www.workday.com/">Workday, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>), a leading provider of solutions to help organizations manage their <a href="https://www.workday.com/en-us/products/human-capital-management/overview.html">people</a> and <a href="https://www.workday.com/en-us/products/financial-management/overview.html">money</a>, and <a href="https://www.equifax.com/">Equifax</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), a global data, analytics and technology company, today announced a new strategic partnership to help make employment and income verifications for Workday customers' employees easier and faster than ever before.

WDAY

Workday And Equifax Announce Strategic Partnership To Help Make Employment And Income Verifications For Workday Customers' Employees Easier

In the latest quarter, 11 analysts provided ratings for Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $300.36, along with a high estimate of $340.00 and a low estimate of $275.00. This upward trend is apparent, with the current average reflecting a 11.89% increase from the previous average price target of $268.44.
<img src="https://www.benzinga.com/files/images/story/2024/1724176904_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Equifax. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$307.00</td>
<td>$277.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$340.00</td>
<td>-</td>
</tr>
<tr>
<td>Arthur Truslove</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$304.00</td>
<td>$263.00</td>
</tr>
<tr>
<td>Andrew Steinerman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$300.00</td>
<td>$273.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$305.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$272.00</td>
</tr>
<tr>
<td>George Tong</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$277.00</td>
<td>$246.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$290.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$320.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Heather Balsky</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$286.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Scott Wurtzel</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$275.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Equifax. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Equifax's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Equifax's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Equifax analyst ratings.</a>
<h2>Delving into Equifax's Background</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Breaking Down Equifax's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Equifax displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 8.57%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 11.46%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Equifax's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.54%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Equifax's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.34%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Equifax's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.17, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 11 Analyst Projections For Equifax

Goldman Sachs analyst George Tong maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Neutral and raises the price target from $277 to $307.

Goldman Sachs Maintains Neutral on Equifax, Raises Price Target to $307

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 10 years by 3.42% on an annualized basis producing an average annual return of 14.16%. Currently, Equifax has a market capitalization of $36.16 billion. 
Buying $100 In EFX: If an investor had bought $100 of EFX stock 10 years ago, it would be worth $374.57 today based on a price of $292.27 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724077810_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Equifax 10 Years Ago Would Be Worth This Much Today

A month has gone by since the last earnings report for Equifax (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/efx#NYSE">EFX</a>). Shares have added about 11.1% in that time frame, outperforming the S&amp;P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Equifax due for a pullback? Before we dive into how investors and analysts have reacted as of late, let&#39;s take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
<h3>Equifax Beats on Q2 Earnings&nbsp;</h3>
Equifax reported impressive second-quarter 2024 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate.
EFX&#39;s adjusted earnings (excluding 51 cents from non-recurring items) were $1.82 per share, outpacing the Zacks Consensus Estimate by 5.8% and increasing by 6.4% on a year-over-year basis. Total revenues of $1.4 billion surpassed the consensus estimate by a slight margin and jumped 8.6% from the year-ago quarter.
<h3>Segmental Information</h3>
Revenues in the Workforce Solutions segment totaled $612.9 million, increasing 5% from the year-ago quarter and beating our expectation of $600.2 million. Within the segment, Verification Services&#39; revenues of $515.9 million were up 9% year over year. Employer Services&#39; revenues of $97 million declined 11% on a year-over-year basis.
USIS segment&#39;s revenues were $478.3 million, grew 7% from the year-ago quarter and missing our anticipation of $481.9 million. Within the segment, Online Information Solutions&#39; revenues of $377.8 million increased 5% year over year. Mortgage Solutions&#39; revenues of $40.4 million jumped 33% from the year-ago quarter. Financial Marketing Services&#39; revenues were $60.1 million, which increased 7% on a year-over-year basis.
Revenues in the International division amounted to $339.3 million, up 17% and 28% year over year on a reported basis and a local currency basis, respectively. The metric missed our estimate of $347.7 million.
Latin America&#39;s revenues of $97.3 million surged 71% from the year-ago quarter on a reported basis and more than 100% on a local currency basis. Revenues from Europe amounted to $88.2 million, up 12% year over year on a reported and local currency basis. Canada&#39;s revenues of $69.2 million increased 4% year over year on a reported basis and 6% on a local currency basis. Revenues from Asia Pacific were $84.6 million, declining 4% from the year-ago quarter on a reported basis and 2% on a local currency basis.
<h3>Operating Results</h3>
Adjusted EBITDA in the second quarter of 2024 amounted to $457.7 million, reflecting a 6.1% increase from the year-ago quarter. The adjusted EBITDA margin was 32%, which declined 70 basis points from the year-ago quarter.
Workforce Solutions&#39; adjusted EBITDA margin was 52.8% compared with 51.5% a year ago. Adjusted EBITDA margin for the USIS division was 33.2% compared with 36% in the second quarter of 2023. The adjusted EBITDA margin for the international segment was 25.6% in comparison with 24.2% in the year-ago quarter.
<h3>Balance Sheet &amp; Cash Flow</h3>
EFX exited the second quarter with cash and cash equivalents of $181.9 million, compared with $201 million at the end of the first quarter of 2024. The company has a long-term debt of $4.7 billion, flat with the preceding quarter.
Cash generated from operating activities amounted to $267.5 million, whereas capital expenditure totaled $136.7 million. The company distributed $48.2 million as dividends in the quarter.
<h3>Q3 and 2024 Outlook</h3>
For the third quarter of 2024, EFX raised its revenue guidance to $1.43-$1.45 billion compared with $1.41-$1.43 billion mentioned previously. It raised the guidance for adjusted earnings per share to $1.75-$1.85 compared with $1.65-$1.75 previously.
For 2024, Equifax raised revenue guidance to $5.69-$5.75 billion compared with $5.67-$5.77 billion previously. The company reduced the adjusted EPS guidance to $7.22-$7.47 compared with $7.2-$7.5 previously.
<h2>How Have Estimates Been Moving Since Then?</h2>
It turns out, estimates revision have trended downward during the past month.
The consensus estimate has shifted -9.82% due to these changes.
<h2>VGM Scores</h2>
Currently, Equifax has an average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren&#39;t focused on one strategy, this score is the one you should be interested in.
<h2>Outlook</h2>
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Equifax has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
<a href="https://www.zacks.com/stock/news/2323215/why-is-equifax-efx-up-11-1-since-last-earnings-report?cid=CS-BENZ-FT-realtime_blog-2323215">To read this article on Zacks.com click here.</a>

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 10 years by 3.27% on an annualized basis producing an average annual return of 14.04%. Currently, Equifax has a market capitalization of $36.12 billion. 
Buying $100 In EFX: If an investor had bought $100 of EFX stock 10 years ago, it would be worth $371.56 today based on a price of $291.94 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723831430_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Equifax Stock In The Last 10 Years

Wells Fargo analyst Jason Haas initiates coverage on Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight rating and announces Price Target of $340.

Initiation

Wells Fargo Initiates Coverage On Equifax with Overweight Rating, Announces Price Target of $340

Broadridge Financial Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/br#NYSE">BR</a>) reported mixed fourth-quarter fiscal 2024 results, with earnings beating the Zacks Consensus Estimate but revenues missing the same.
Adjusted earnings of $3.5 per share beat the Zacks Consensus Estimate by 0.6% and increased 9% from the year-ago quarter. Total revenues of $1.94 billion missed the consensus mark by 1% but were up 6% year over year.
Recurring revenues of $1.3 billion increased 5% year over year on a reported, as well as a constant currency basis.
The company&#39;s shares have gained 25.5% over the past year compared with the 5.9% rally of the industry&nbsp;it belongs to and the 15% growth of the Zacks S&amp;P 500 Composite.
<div class="chart_embed">
<h3>Broadridge Financial Solutions, Inc. Price, Consensus and EPS Surprise</h3>
<h3><img alt="Broadridge Financial Solutions, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/7a/1722955912.png" style="height:315px; width:600px" title="" /></h3>
Broadridge Financial Solutions, Inc. price-consensus-eps-surprise-chart | Broadridge Financial Solutions, Inc. Quote
</div>
<h3>Other Key Q4 Metrics</h3>
Revenues in the Investor Communication Solutions segment increased 6% from the year-ago quarter&#39;s level to $1.53 billion, slightly above our estimate of $1.52 billion. The Global Technology and Operations segment&#39;s revenues amounted to $416 million, lagging our estimate of $437.5 million but increasing 4% on a year-over-year basis.
Adjusted operating income of $559 million increased 5% from the year-ago quarter. Adjusted operating income margin of 28.8% decreased slightly year over year.
Broadridge exited the quarter with a cash and cash equivalents balance of $304.4 million compared with $235.6 million at the end of the preceding quarter. Long-term debt was $3.4 billion compared with $3.5 billion at the end of the prior quarter.
The company generated $721 million of cash in operating activities and capex was $17.8 million in the quarter. It paid out $94.3 million in dividends.
<h3>Fiscal 2025 Guidance</h3>
Broadridge expects recurring revenue growth to be 5-7%. Adjusted earnings per share growth is expected to be 8-12%. Adjusted operating income margin is estimated to be around 20%.
Broadridge currently carries a Zacks Rank #3 (Hold).
<h3>Recent Earnings Snapshots</h3>
Omnicom (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/omc#NYSE">OMC</a>) reported impressive second-quarter 2024 results, wherein both earnings and revenues beat the Zacks Consensus Estimate.
OMC&#39;s earnings of $1.95 per share beat the consensus estimate by 3.7% and increased 7.7% year over year. Total revenues of $3.9 billion surpassed the consensus estimate by 1.1% and increased 6.8% year over year.
Equifax (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/efx#NYSE">EFX</a>) reported better-than-expected second-quarter 2024 results.
EFX&#39;s adjusted earnings were $1.82 per share, beating the consensus estimate by 5.8% and increasing 6.4% from the year-ago quarter. Total revenues of $1.4 billion missed the consensus estimate by a slight margin but increased 8.6% from the year-ago quarter.
ManpowerGroup (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/man#NYSE">MAN</a>) reported mixed second-quarter 2024 results, with earnings beating the Zacks Consensus Estimate but revenues missing the same.
Quarterly adjusted earnings of $1.3 per share surpassed the consensus mark by 2.4% but declined 17.7% year over year. Revenues of $4.5 billion lagged the consensus mark by a slight margin and dipped 6.9% year over year.
<a href="https://www.zacks.com/stock/news/2317230/broadridge-s-br-q4-earnings-surpass-estimates-rise-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2317230">To read this article on Zacks.com click here.</a>

Broadridge's Q4 Earnings Surpass Estimates, Rise Y/Y

Aptiv PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aptv#NYSE">APTV</a>)&nbsp;reported mixed second-quarter 2024 results, with earnings beating the Zacks Consensus Estimate but revenues missing the same.
Adjusted earnings of $1.58 per share beat the Zacks Consensus Estimate by 15.3% and increased 26.4% year over year. Revenues of $5.1 billion missed the Zacks Consensus Estimate by 5.1% and decreased 2.9% year over year.
The company&#39;s adjusted revenues declined 2% year over year. Adjusted revenues declined 3% in North America and stayed flat in Asia, including a 1% increase in China. Revenues declined 2% in Europe and 13% in South America.
APTV&#39;s stock has lost 35% of its value in the past year against the 35% rally of the industry it belongs to.
<div class="chart_embed">
<h3>Aptiv PLC Price, Consensus and EPS Surprise</h3>
<img alt="Aptiv PLC Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/d3/1722526947.png" style="height:265px; width:600px" title="" />
Aptiv PLC price-consensus-eps-surprise-chart | Aptiv PLC Quote
</div>
<h3>Other Quarterly Numbers</h3>
Signal and Power Solutions&#39; revenues of $3.5 billion declined 5% year over year. The Advanced Safety and User Experience segment&#39;s revenues increased 1% year over year to $1.6 billion.
Adjusted operating income was $606 million, up 14.3% from the figure reported in the year-ago quarter. Adjusted operating income margin was 11.1%, up 180 basis points year over year.
Aptiv exited the quarter with a cash and cash equivalent balance of $1.4 billion compared with the prior quarter&#39;s $941 million. Long-term debt was $5.5 billion compared with $4.7 billion in the previous quarter.
Total available liquidity at the end of the quarter was $4.6 billion compared with $3.4 billion recorded at the end of the prior quarter. In the quarter, the company generated $643 million in cash from operating activities.
<h3>Updated 2024 Outlook</h3>
Aptiv expects revenues to be between $20.1 billion and $20.4 billion compared with the prior expectation of $20.85-$21.45 billion, and lower than the current Zacks Consensus Estimate of $21.07 billion.
Adjusted EPS is expected between $6.15 and $6.45 compared with the previous anticipation of $5.8 and $6.3, and higher than the Zacks Consensus Estimate of $5.94. Adjusted operating income margin is anticipated between 11.8% and 12.1% compared with the previous guidance of 11.6% and 12%. Capital expenditure is expected to be $900 million against the previous expectation of $1 billion.
Adjusted EBITDA margin is now expected between 15.4% and 15.7%, while the previous expectation was 15% to 15.3%. The adjusted effective tax rate is expected to be around 16.5% compared with the previous expectation of 17.5%.
Currently, Aptiv carries a Zacks Rank #4 (Sell).
<h3>Recent Earnings Snapshots</h3>
Omnicom (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/omc#NYSE">OMC</a>) reported impressive second-quarter 2024 results, wherein both earnings and revenues beat the Zacks Consensus Estimate.
OMC&#39;s earnings of $1.95 per share beat the consensus estimate by 3.7% and increased 7.7% year over year. Total revenues of $3.9 billion surpassed the consensus estimate by 1.1% and increased 6.8% year over year.
Equifax (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/efx#NYSE">EFX</a>) reported better-than-expected second-quarter 2024 results.
EFX&#39;s adjusted earnings were $1.82 per share, beating the consensus estimate by 5.8% and increasing 6.4% from the year-ago quarter. Total revenues of $1.4 billion missed the consensus estimate by a slight margin but increased 8.6% from the year-ago quarter.
ManpowerGroup (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/man#NYSE">MAN</a>) reported mixed second-quarter 2024 results, with earnings beating the Zacks Consensus Estimate but revenues missing the same.
Quarterly adjusted earnings of $1.3 per share surpassed the consensus mark by 2.4% but declined 17.7% year over year. Revenues of $4.5 billion lagged the consensus mark by a slight margin and dipped 6.9% year over year.
<a href="https://www.zacks.com/stock/news/2314598/aptiv-s-aptv-q2-earnings-beat-estimates-increase-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2314598">To read this article on Zacks.com click here.</a>

Aptiv's Q2 Earnings Beat Estimates, Increase Y/Y

Citigroup analyst Arthur Truslove maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and raises the price target from $263 to $304.

Citigroup Maintains Buy on Equifax, Raises Price Target to $304

JP Morgan analyst Andrew Steinerman maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and raises the price target from $273 to $300.

JP Morgan Maintains Overweight on Equifax, Raises Price Target to $300

Stifel analyst Shlomo Rosenbaum maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and raises the price target from $265 to $305.

Stifel Maintains Buy on Equifax, Raises Price Target to $305

Oppenheimer analyst Owen Lau maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and raises the price target from $272 to $300.

Oppenheimer Maintains Outperform on Equifax, Raises Price Target to $300

Goldman Sachs analyst George Tong maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Neutral and raises the price target from $246 to $277.

Goldman Sachs Maintains Neutral on Equifax, Raises Price Target to $277

Baird analyst Jeffrey Meuler maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and raises the price target from $260 to $290.

Baird Maintains Outperform on Equifax, Raises Price Target to $290

Barclays analyst Manav Patnaik maintained a Buy rating on Equifax (EFX – Research Report) today and set a price target of $300.00. The company's sh...

Barclays Remains a Buy on Equifax (EFX)

Tracking Al Gore's Generation Investment Management Portfolio - Q2 2024 Update

TransUnion cut to Hold, Equifax reiterated at Buy, as Needham gets more selective

Investors will increasingly focus on upcoming economic data to gauge soft landing odds that have helped drive stock performance in 2024. Given an evolving macroeconomic landscape, it could be wise to invest in under-the-radar socks Workday (WDAY), CrowdStrike (CRWD), and Novavax (NVAX), which could be tomorrow's blue chips. Read more... In the evolving market landscape, savvy investors always look for the next big thing—those hidden gems that could transform into tomorrow's blue-chip giants. While household names like Apple and Amazon dominate headlines, many promising companies remain under the radar, quietly laying the groundwork for massive future growth.
Hence, let's look at lesser-known, fundamentally sound stocks, Workday, Inc. (<a href="https://stocknews.com/stock/WDAY/">WDAY</a>), CrowdStrike Holdings, Inc. (<a href="https://stocknews.com/stock/CRWD/">CRWD</a>), and Novavax, Inc. (<a href="https://stocknews.com/stock/NVAX/">NVAX</a>), which hold the potential to deliver substantial returns for those who spot them early and could be tomorrow's blue chips.
The economy rose faster than expected during the second quarter, with consumer spending, business investment, and inventories adding up to the Gross Domestic Product (GDP) growth. GDP increased at a <a href="https://www.reuters.com/markets/us/us-economic-growth-regains-steam-second-quarter-inflation-slows-2024-07-25/">2.8% annualized rate</a> last quarter, which was double the 1.4% growth in the first quarter. Economists polled by Reuters estimated GDP rising at a 2% rate.
Moreover, the Federal Reserve Chair Jerome Powell recently <a href="https://www.cnbc.com/2024/08/23/fed-chair-powell-indicates-interest-rate-cuts-ahead-the-time-has-come-for-policy-to-adjust.html">indicated interest rate cuts</a> ahead, though he didn't provide exact indications on timing or extent. Investors are focusing on economic data to gauge a soft landing that has helped drive stocks so far this year.
Stocks witnessed gains on Friday after Powell's comments, with the Dow Jones surging 1.14%, while the <a href="https://www.cnbc.com/2024/08/22/stock-market-today-live-updates.html">Nasdaq Composite rose 1.47%</a> and the S&amp;P 500 gained 1.15%.
Amid an improving macroeconomic backdrop, investors could consider buying under-the-radar stocks such as WDAY, CRWD, and NVAX, which could be future blue-chip powerhouses.
Let's discuss the fundamentals of the featured stocks in detail:
Workday, Inc. (<a href="https://stocknews.com/stock/WDAY/">WDAY</a>)
WDAY provides enterprise cloud applications that help its global customers plan, execute, analyze, and extend to diverse applications and environments to manage their business and operations.
On August 22, WDAY and Equifax Inc. (<a href="https://stocknews.com/stock/EFX/">EFX</a>), a global data, analytics, and technology company, announced a strategic partnership to help modernize the employment and income verification process for Workday customers' employees.
Matthew Brandt, senior vice president of global partners at Workday, said, "This partnership improves the employee experience by simplifying and speeding up the process by which they secure loans and government benefits, which frees up HR teams to focus on more meaningful work such as employee performance and wellbeing."
On August 20, WDAY announced the global release of Workday Payroll powered by Strada. The new AI-driven global HR and payroll solution offers organizations a unified view of their finance, HR, and payroll data, enhancing data accuracy, supporting compliance, and informing strategic initiatives that drive business growth and success.
For the second quarter that ended July 31, 2024, WDAY's revenue increased 16.7% year-over-year to $2.09 billion. Its non-GAAP <a href="https://www.investopedia.com/terms/o/operatingincome.asp#:~:text=Operating%20income%20is%20an%20accounting,of%20goods%20sold%20(COGS).">operating income</a> grew 23% from the year-ago value to $518 million. Its non-GAAP net income per share rose 22.4% from the prior year's period to $1.75. Its free cash flows were $516 million, up 43.3% year-over-year.
Analysts expect WDAY's revenue and EPS for the third quarter (ending October 2024) to increase 14.1% and 14.1% year-over-year to $2.13 billion and $1.75, respectively.  Moreover, the company surpassed the consensus revenue and EPS estimates in all four trailing quarters.
Shares of WDAY have surged 13.4% over the past month to close the last trading session at $259.95.
WDAY's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect this promising outlook. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
WDAY has an A grade for Growth and a B for Sentiment and Quality. Within the <a href="https://stocknews.com/category/software-application/">Software – Application</a> industry, it is ranked #22 out of 128 stocks. To see the additional ratings of WDAY for Value, Momentum, and Stability, <a href="https://stocknews.com/stock/WDAY/">click here</a>.
CrowdStrike Holdings, Inc. (<a href="https://stocknews.com/stock/CRWD/">CRWD</a>)
CRWD offers cybersecurity solutions globally. Its unified platform offers cloud-delivered protection of endpoints, cloud workloads, identity, and data. It provides corporate endpoint and cloud workload security, security and vulnerability management, IT operations management, data protection, security orchestration, and AI-powered workflow automation.
On June 26, CRWD announced that it exceeded $1 billion in total sales over the lifetime of its partnership with CDW Corporation (<a href="https://stocknews.com/stock/CDW/">CDW</a>), a prominent multi-brand provider of IT solutions. CrowdStrike and CDW jointly lead cybersecurity transformation for thousands of organizations globally through the AI-native <a href="https://www.crowdstrike.com/platform/">CrowdStrike Falcon&#xAE; platform</a>.
On June 18, CRWD partnered with Hewlett Packed Enterprise (<a href="https://stocknews.com/stock/HPE/">HPE</a>) to <a href="https://ir.crowdstrike.com/news-releases/news-release-details/crowdstrike-collaborates-hewlett-packard-enterprise-secure-end">secure end-to-end AI innovation</a>, including large language models (LLMs), accelerated by NVIDIA Corporation (<a href="https://stocknews.com/stock/NVDA/">NVDA</a>). Integrating the Falcon platform with HPE GreenLake cloud and OpsRamp AIOps unifies security and IT teams in monitoring accelerated AI workload IT alerts and adversary activity.
During the first quarter that ended April 30, 2024, CRWD's total revenue increased 33% year-over-year to $921.04 million. Its gross profit rose 33% from the year-ago value to $696.03 million. Its non-GAAP income from operations grew 71.5% year-over-year to $198.74 million.
Further, non-GAAP net income attributable to CrowdStrike came in at $231.67 million and $0.93 per share, up 69.9% and 63.2% from the prior year's quarter, respectively. Its free cash flow rose 41.8% year-over-year to $322.46 million.
Analysts expect CRWD's revenue for the second quarter (ended July 2024) to increase 31% year-over-year to $958.36 million. The consensus EPS estimate of $0.97 for the current quarter reflects a 30.5% year-over-year improvement. Moreover, the company has topped consensus revenue and EPS estimates in each of the trailing four quarters.
CRWD's stock has gained 6.4% year-to-date to close the last trading session at $271.54.
CRWD's sound fundamentals are reflected in its POWR Ratings. The stock has an A grade for Growth and a B for Quality. Within the B-rated <a href="https://stocknews.com/category/software-security/">Software – Security</a> industry, CRWD is ranked #18 out of 23 stocks.
<a href="https://stocknews.com/stock/CRWD/">Click here</a> to access additional ratings of CRWD (Value, Stability, Sentiment, and Momentum).
Novavax, Inc. (<a href="https://stocknews.com/stock/NVAX/">NVAX</a>)
NVAX is a biotechnology company that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases.
On July 2, NVAX submitted a request for authorization to Health Canada for its 2024-2025 Formula COVID-19 vaccine (NVX-CoV2705) for individuals aged 12 and older.
This filing aligns with the guidance from the National Advisory Committee on Immunization (NACI) to use the latest selected strain and the guidance from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and the World Health Organization (WHO).
NVAX reported total revenue of $415.48 million in the second quarter that ended June 30, 2024. Its income from operations grew 190.3% from the prior year's quarter to $161 million. Its net income was $162.38 million, or $0.99 per share, up 179.9% and 70.7% year-over-year, respectively.
Furthermore, as of June 30, 2024, the company's cash and cash equivalents stood at $680.16 million, compared to $568.51 million as of December 31, 2023.
NVAX's stock has soared 126.7% over the past six months and 33.1% over the past year to close the last trading session at $11.99.
NVAX's sound fundamentals are reflected in its POWR Ratings. The stock has a B grade for Value and Growth. It is ranked #56 among 339 stocks in the <a href="https://stocknews.com/category/biotech/">Biotech</a> industry.
<a href="https://stocknews.com/stock/NVAX/">Click here</a> to access NVAX's ratings for Momentum, Stability, Quality, and Sentiment.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
WDAY shares rose $0.05 (+0.02%) in premarket trading Monday. Year-to-date, WDAY has declined -5.82%, versus a 19.19% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Mangeet Kaur Bouns</h2> <img src='https:/wp-content/uploads/2022/01/Mangeet-Kaur-Bouns_Image-4.jpg' style="float:left; padding:5px;width:125px;">Mangeet's keen interest in the stock market led her to become an investment researcher and financial journalist. Using her fundamental approach to analyzing stocks, Mangeet's looks to help retail investors understand the underlying factors before making investment decisions.<a href="https://stocknews.com/authors/?author=mangeet-kaurbouns">More...</a>The post <a href=https://stocknews.com/news/wday-nvda-efx-crwd-hpe-nvax-3-under-the-radar-stocks-that-could-be-tomorrows-blue-chips/>3 Under-the-Radar Stocks That Could Be Tomorrow's Blue Chips</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Under-the-Radar Stocks That Could Be Tomorrow's Blue Chips

Equifax: A Potential Beneficiary Of Interest Rate Cut

50 stocks to invest during the bull steepening – Part 1

Software companies are the key players in the future of business and technology, thus creating a robust environment. Given this backdrop, it could be wise to invest in software stocks that Wall Street seems to love: Intuit (INTU), Workday (WDAY), and Salesforce (CRM). Continue reading… In today's digital world, software companies have become an essential part of the economy, offering both growth and stability in the market. These companies are fueled by generative AI integration in their systems, which makes them more efficient and faster.
These new and evolved advancements are creating an opportunity for investors to invest in software-providing stocks such as Intuit Inc. (<a href="https://stocknews.com/stock/INTU/">INTU</a>), Salesforce, Inc. (<a href="https://stocknews.com/stock/CRM/">CRM</a>), and Workday, Inc. (<a href="https://stocknews.com/stock/WDAY/">WDAY</a>), which are currently finding favors on Wall Street.
Software companies are seeing significant expansion opportunities with the rising demand for cloud computing, AI, cybersecurity, and remote collaboration tools. According to a <a href="https://www2.deloitte.com/us/en/pages/about-deloitte/articles/sustainable-competitive-industry-advantage.html">Deloitte report</a>, nearly 80% of surveyed business leaders expect generative AI to drive substantial transformation within their organizations in the next three years.
Furthermore, the global market software revenue is projected to be <a href="https://www.grandviewresearch.com/industry-analysis/software-market-report#:~:text=USD%201%2C397.31%20billion">$1.39 trillion by 2030</a>, exhibiting a CAGR of 11.5%. This data underscores the strong demand for software solutions across various sectors.
Considering these conducive trends, let's examine the <a href="https://stocknews.com/category/software-application/">Software - Application</a> industry stocks in detail, beginning with the third choice:
Stock #3: Intuit Inc. (<a href="https://stocknews.com/stock/INTU/">INTU</a>)
INTU is a financial technology platform that helps consumers and small businesses prosper by delivering financial management, compliance, and marketing products and services. It operates through four segments: Small Business &amp; Self-Employed; Consumer; Credit Karma; and ProTax. 
On September 4, INTU announced major enhancements to its proprietary Generative AI Operating System (GenOS) that's accelerating development velocity at scale across the company's products and services.
The GenOS includes GenOS AI Workbench, which simplifies and streamlines end-to-end app development and enhancements to GenStudio, GenRuntime, and GenUX components.
On June 20, INTU and the Los Angeles Urban League announced the agreement to extend their partnership with the IDEAS (Invest, Develop, Empower, Accelerate, and Scale) Program. This program will now expand to a total of 100 small business owners, helping them grow and save time and money.
INTU's total net revenue for the fourth quarter (ended July 31, 2024) increased 17.4% year-over-year to $3.18 billion. Its non-GAAP <a href="https://www.investopedia.com/terms/o/operatingincome.asp">operating income</a> grew 16.4% from the prior year's quarter to $730 million. The company's non-GAAP net income for the quarter amounted to $730 million or $1.99 per share, representing an increase of 20.6% from the same period last year.
As per the forward-looking guidance for the fiscal year 2025, INTU forecasts revenue to be between $18.16 billion and $18.35 billion. The company also expects non-GAAP EPS between $19.16 and $19.36 and non-GAAP operating income to range from $7.24 billion to $7.14 billion.
The consensus revenue estimate of $3.88 billion for the fiscal second quarter (ending January 2025) represents a 14.7% increase year-over-year. The consensus EPS estimate of $3.25 for the same quarter indicates a 23.6% improvement year-over-year. The company has an impressive earnings surprise history; it surpassed the consensus EPS estimates in each of the trailing four quarters.
Over the past year, the stock has surged 13.9%, closing the last trading session at $626.99.
Of 22 analysts that rated INTU, 19 rated it Buy, while three rated it Hold. The 12-month median price target of $741.42 indicates <a href="https://www.tipranks.com/stocks/intu/forecast">an 18.3% upside potential</a> from the last closing price. The price targets range from a low of $600 to a high of $795.
INTU's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect this robust outlook. The stock has an overall rating of B, which equates to Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
INTU has a B grade for Growth, Sentiment, and Quality. It is ranked #33 out of 125 stocks in the <a href="https://stocknews.com/category/software-application/">Software - Application</a> industry. <a href="https://stocknews.com/stock/INTU/">Click here</a> to see the additional ratings for INTU (Value, Momentum, and Stability).
Stock #2: Workday, Inc. (<a href="https://stocknews.com/stock/WDAY/">WDAY</a>)
WDAY is a global provider of enterprise cloud applications for finance and human resources. It helps customers plan, execute, analyze, and extend to its varied applications to manage their business and operations.
On August 22, WDAY and Equifax Inc. (<a href="https://stocknews.com/stock/EFX/">EFX</a>), a global data analytics and technology company, announced a strategic partnership to help make employment and income verifications for WDAY customers easier and faster with more efficiency and reduced costs.
In the same month, WDAY announced the global release of Workday Payroll powered by Strada. This new AI-powered global HR and payroll solution gives organizations a unified view of their finance, anticipates trends, and customizes payroll services within the organization.
For the second quarter of 2025, which ended on July 31, WDAY's total revenues increased 16.7% year-over-year to $2.09 billion, and its non-GAAP operating income stood at $518 million, indicating a 23% growth from the prior-year quarter period.
Its net income rose 67.1% from the year-ago value to $132 million, while its non-GAAP net income per share stood at $1.75, up 22.4% year-over-year.  Also, the company's free cash flow grew 43.3% from the year-ago value to $516 million.
The company has updated its fiscal year 2025 guidance. It now expects its subscription revenue to range between $7.700 billion and $7.7325 billion, representing a growth of approximately 17%. Additionally, WDAY expects its non-GAAP operating margin to be 25.25%.
Analysts expect WDAY's revenue for the third quarter ending October 31, 2024, to increase 14.1% year-over-year to $2.13 billion, while its EPS for the same period is expected to increase 14.2% from the prior-year quarter to $1.75. The company surpassed consensus revenue and EPS estimates in each of the trailing four quarters, which is impressive.
WDAY shares have surged 19.6% over the past month and 17.6% over the past three months to close the last trading session at $253.52.
Based on 31 Wall Street analysts offering 12-month price targets for WDAY in the last three months, <a href="https://www.tipranks.com/stocks/wday/forecast">the average target price is $287.73</a>, indicating a 13.5% change from the last price, with a high forecast of $352 and a low forecast of $240.
WDAY's bright prospects are reflected in its POWR Ratings. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
It also has an A grade for Growth and a B for Sentiment and Stability. Within the same industry, it is ranked #28 out of 125 stocks. <a href="https://stocknews.com/stock/WDAY/">Click here</a> to see WDAY's ratings for Value, Momentum, and Stability.
Stock #1: Salesforce, Inc. (<a href="https://stocknews.com/stock/CRM/">CRM</a>)
CRM provides Customer Relationship Management (CRM) technology that brings companies and customers together worldwide. It supports third-party development and offers global sales, service, and subscription services, enabling data storage, lead tracking, and issue resolution.
On September 5, CRM announced its acquisition of Own Company, a leading provider of data protection and data management solutions, for $1.90 billion in cash. This acquisition is set to enhance CRM's ability to offer customers robust data protection and management solutions.
On July 24, the company announced a strategic partnership with WDAY to create an AI-powered employee service agent to boost productivity, lower costs, and improve the employee experience. The partnership will also deepen WDAY's integration with Slack for seamless collaboration.
In the fiscal 2025 second quarter that ended on July 31, 2024, CRM's total revenue increased 8.4% year-over-year to $9.33 billion. The company reported non-GAAP income from operations of $3.14 billion, indicating a 15.5% growth from the prior year quarter with a non-GAAP operating margin of 33.7% (up 210 bps year-over-year). Its free cash flow increased 20.2% year-over-year to $755 million.
CRM's non-GAAP net income came in at $2.49 million, up 19.1% year-over-year, while its non-GAAP net income per share grew 20.8% from the year-ago value to $2.56.
For the fiscal year 2025, the company's non-GAAP operating margin is projected to be 32.8%, with EPS anticipated to fall between $6.05 and $6.13. On a consolidated adjusted basis, its non-GAAP EPS is expected to range from $10.03 to $10.11.
Street expects CRM's revenue for the fiscal fourth quarter (ending October 2024) to increase 7.2% year-over-year to $9.35 billion. Its EPS for the same period is expected to register a 16% growth from the prior year, settling at $2.45. In addition, it surpassed the consensus revenue and EPS estimates in each of the trailing four quarters, which is promising.
Shares of CRM have gained 9.3% over the past year to close the last trading session at $245.76.
Based on 38 Wall Street analysts offering 12-month price targets for CRM in the last three months, <a href="https://www.tipranks.com/stocks/crm/forecast">the average target price is $307.38</a>, indicating a 25.1% change from the last price, with a high forecast of $352.00 and a low forecast of $236.00.
It's no surprise that CRM has an overall rating of B, equating to a Buy in our POWR Ratings system. It has a B grade for Sentiment and Quality. Out of 125 stocks in the Software - Application industry, CRM is ranked #14.
Beyond what is stated above, we've also rated CRM for Growth, Value, Momentum, and Stability. Get all CRM ratings <a href="https://stocknews.com/stock/CRM/">here</a>.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
CRM shares were trading at $245.81 per share on Tuesday afternoon, up $0.05 (+0.02%). Year-to-date, CRM has declined -6.32%, versus a 16.08% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Anushka Dutta</h2> <img src='https:/wp-content/uploads/2021/08/Anushka-Dutta_Headshot_3.jpg' style="float:left; padding:5px;width:125px;">Anushka is an analyst whose interest in understanding the impact of broader economic changes on financial markets motivated her to pursue a career in investment research.<a href="https://stocknews.com/authors/?author=anushka-dutta">More...</a>The post <a href=https://stocknews.com/news/crm-intu-wday-efx-3-software-stocks-that-wall-street-loves-right-now/>3 Software Stocks That Wall Street Loves Right Now</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Software Stocks That Wall Street Loves Right Now

Morgan Stanley analyst Toni Kaplan maintained a Hold rating on Equifax (EFX – Research Report) today and set a price target of $271.00. The company...

Equifax (EFX) Receives a Hold from Morgan Stanley

In a report released today, Manav Patnaik from Barclays maintained a Buy rating on Equifax (EFX – Research Report), with a price target of $380.00....

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Equifax

Equifax (EFX) Forecast

Equifax (NYSE:EFX) Stock, Quote.Headers.trade-ideas